microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3

Circular RNA_PDHX Promotes the Proliferation and Invasion of Prostate Cancer by Sponging MiR-378a-3p

(2021) Yuanshen Mao et al.   Frontiers in Cell and Developmental Biology

MiR‐378a‐3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation

(2021) Fuliang Qian et al.   Clinical and Translational Medicine

m6A-induced LINC00958 promotes breast cancer tumorigenesis via the miR-378a-3p/YY1 axis

(2021) Dongwen Rong et al.   Cell Death Discovery

Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation

(2021) Meng-yun Ke et al.   CANCER LETTERS

Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling

(2021) Qianxi Yang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Usnic acid suppresses cervical cancer cell proliferation by inhibiting PD‐L1 expression and enhancing T‐lymphocyte tumor‐killing activity

(2021) Tong Xin Sun et al.   PHYTOTHERAPY RESEARCH

Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma

(2021) Julia Peña-Asensio et al.   Cancers

MicroRNAs: Regulators of immunological reactions in hepatocellular carcinoma

(2021) Meenakshi Gupta et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity

(2020) Sara Verdura et al.   Aging-US

The Complex Network between MYC Oncogene and microRNAs in Gastric Cancer: An Overview

(2020) Ana Carolina Anauate et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming

(2020) Yang Liu et al.   Journal of Hematology & Oncology

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

(2020) Alessio Cortellini et al.   OncoImmunology

Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview

(2020) Cristina Elena Staicu et al.   Cells

Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment

(2020) Hyo Jung Cho et al.   EUROPEAN RADIOLOGY

microRNAs involved in T‐cell development, selection, activation, and hemostasis

(2020) Behnam Emamgolizadeh Gurt Tapeh et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer

(2020) Naoko Komura et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner

(2020) Man Zhu et al.   PHARMACOLOGICAL RESEARCH

IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma

(2020) Wenjie Zhang et al.   Journal for ImmunoTherapy of Cancer

Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma

(2020) Chiao-Fang Teng et al.   Viruses-Basel

Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis

(2020) Cheng-Hao Tseng et al.   Lancet Gastroenterology & Hepatology

The multifaceted roles of microRNAs in differentiation

(2020) Himani Galagali et al.   CURRENT OPINION IN CELL BIOLOGY

Britannin stabilizes T cell activity and inhibits proliferation and angiogenesis by targeting PD-L1 via abrogation of the crosstalk between Myc and HIF-1α in cancer

(2020) Yu Fan Zhang et al.   PHYTOMEDICINE

Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC

(2020) Xiuzhu Gao et al.   Journal of Hepatocellular Carcinoma

Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling

(2020) Shuxiang Wu et al.   CANCER LETTERS

The long noncoding RNA AK002107 negatively modulates miR‐140‐5p and targets TGFBR1 to induce epithelial–mesenchymal transition in hepatocellular carcinoma

(2019) Yun‐Hua Tang et al.   Molecular Oncology

MicroRNAs play an essential role in autophagy regulation in various disease phenotypes

(2019) Yunyi Zhao et al.   BIOFACTORS

MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis

(2019) Solmaz Shirjang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Recent advances on nanomaterials-based fluorimetric approaches for microRNAs detection

(2019) Mahdi Norouzi et al.   Materials Science & Engineering C-Materials for Biological Applications

MicroRNAs as modulators of T cell functions in cancer

(2018) Stefan Emming et al.   CANCER LETTERS

Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study

(2018) Antonietta Romano et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma

(2018) Alejandro Forner et al.   LANCET

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

(2018) Daniele V. F. Tauriello et al.   NATURE

Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF)

(2018) Hendrik‐Tobias Arkenau et al.   ONCOLOGIST

TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway

(2018) Dian Xiong et al.   CANCER SCIENCE

EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions

(2018) Sho Sasaki et al.   Gastric Cancer

LINC01433 promotes hepatocellular carcinoma progression via modulating the miR-1301/STAT3 axis

(2018) Haijin Huang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation

(2016) Laurie D. Snyder et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Hepatitis C virus NS3 protein enhances cancer cell invasion by activating matrix metalloproteinase-9 and cyclooxygenase-2 through ERK/p38/NF-κB signal cascade

(2015) Lili Lu et al.   CANCER LETTERS

Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients

(2013) H-B Jie et al.   BRITISH JOURNAL OF CANCER

Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells

(2013) Raquel Ordoñez et al.   JOURNAL OF PINEAL RESEARCH

Phenotypic and functional characteristics of CD4+CD39+ FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in cancer patients

(2012) Patrick J. Schuler et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC

(2012) Marc R Fabian et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

What are regulatory T cells (Treg) regulating in cancer and why?

(2012) Theresa L. Whiteside   SEMINARS IN CANCER BIOLOGY

Liver-specific overexpression of matrix metalloproteinase 9 (MMP-9) in transgenic mice accelerates development of hepatocellular carcinoma

(2011) Florian R. Thieringer et al.   MOLECULAR CARCINOGENESIS